OBJECTIVE: The gene that codes for a novel uncoupling protein, UCP2, has been linked to obesity in animal models. Markers encompassing the UCP2 locus have been linked to energy expenditure in humans. We studied the role of a common amino acid substitution, replacing an alanine (A) with a valine (V) at codon 55, of the coding region of the UCP2 gene for 24-h energy expenditure and respiratory quotient (RQ) in healthy subjects METHODS: 24-h energy expenditure and RQ were measured in calorimeters in 60 healthy subjects. The UCP2 polymorphism was determined by restriction fragment length polymorphism-generating polymerase chain reaction. RESULTS: Age, gender and body fat were not different between groups, the number of subjects in each groups was AaA: 35% (n 21), AaV: 48% (n 29), and VaV: 17% (n 10). Twenty-four-hour energy expenditure, adjusted for fat-free mass, fat mass, and spontaneous physical activity, was 311 kJad lower (95% con®dence interval: 24 ± 598 kJad, P 0.03) in the VaV homozygotes than in the AaA and AaV genotypes. The VaV had $ 20% higher 24-h spontaneous physical activity, particularly higher at night (P`0.005). Energy expenditure due to higher spontaneous physical activity counteracted the VaV group's lower 24-h resting energy expenditure for a given body size and composition. 24-h RQ adjusted for energy balance, age, sex and spontaneous physical activity, was higher in the VaV homozygotes than in the AA and AaV groups (P`0.05). CONCLUSIONS: Subjects with the VaV genotype of the UCP2 gene exhibit an enhanced metabolic ef®ciency and lower fat oxidation than the AaA and AaV genotypes.
Introduction
Obesity is an increasing health problem and an improved understanding of its causes has high priority. A number of studies have indicated the 40 ± 70% of the variation in body mass index and fat mass may be genetically determined. 1 Although several singlegene mutations have been shown to cause obesity in animal models, the situation in most forms of human obesity is much more complex. With rare exceptions, the most common forms of human obesity are thought to arise from the interactions of multiple genes, environmental factors, and behaviour, and obesity must be considered a multifactorial disorder. Among the genetically determined factors that may contribute to weight gain is a low energy expenditure (EE) for a given body size and composition. 2, 3 In prospective studies it has been shown that a low level of EE for a given body size and composition is a risk factor for body weight gain. 4 Moreover, a meta-analysis has shown that formerly obese individuals are 5-fold more likely to have a low adjusted resting EE than matched controls. 5 It is likely that the recently discovered uncoupling protein-2, (UCP2), may be involved in the regulation of EE and fat oxidation. 6 UCP's are a group of mitochondrial proteins which dissipate the proton electrochemical gradient across the mitochondrial membrane. By this mechanism UCP may uncouple substrate oxidation from conversion of ADP to ATP, leading to generation of heat and thus increased EE. UCP1 is expressed exclusively in mammalian brown adipose tissue, which is only present in small amounts and lacks functional activity in humans. 7 By contrast, the gene encoding a novel human uncoupling protein, UCP2, is expressed in a wide range of human tissues, including important sites of thermogenesis such as skeletal muscle, heart, liver and kidney. 8 It has been demonstrated that UCP2 affects the mitochondrial activity and can, to a certain extent, uncouple the respiration. 8 Bouchard et al 9 studied potential linkage relationships between microsatellite markers encompassing the UCP2 gene locus with resting EE and body fatness, and found that three markers were linked to resting EE in adult humans. This ®nding warranted further studies of DNA sequence variation in the gene itself, and a common amino acid polymorphism was recently reported. 10 It consists of one nucleotide substitution located at codon 55, replacing an alanine (gcc) with a valine (gtc), and the amino acid polymorphism was present in 69% of the examined subjects. 10 The occurrence of this polymorphism was not associated with obesity, 10 but this does not exclude that it may in¯uence the energy expenditure and oxidative pattern since compensatory mechanisms may mask the possible effect on obesity. We therefore found it pertinent to investigate whether this polymorphism in the UCP2 gene plays a role for 24-h EE and RQ in humans.
Subjects and methods

Subjects
Healthy 30-y old subjects were recruited randomly from two ongoing Danish population surveys (`Glostrup Population Surveys' and`Sund Valby') and were included in the study provided they had at least one full sibling eligible for inclusion and were proved, by medical history and biomedical screening, to be in good health without endocrine disorders. In addition, it was required that they must not be dieting or taking any regular medication other than oral contraceptives. A total of 32 probands and their 39 full siblings entered the study. Their anthropometric and physiological characteristics have previously been presented. 11 We failed to get DNA from 11 subjects, so only 60 subjects participated in this analysis. Prior to participation informed consent was obtained from all subjects. The study was approved by the Ethical Committee of Copenhagen and was in accordance with the principles of the Declaration of Helsinki II.
Body weight and composition
Body weight was measured on a decimal scale (Seca model 707, Copenhagen). Body composition was estimated by the impedance method using an Animeter (HTS-Engineering Inc., Odense, Denmark). 12 Anthropometric measurements were performed in the morning after an overnight fast.
24-h energy expenditure
24-h EE was measured in two open-circuit respiration chambers, which have been described in detail elsewhere. 11, 12 The subjects received a weight maintenance diet providing 48% energy from carbohydrate, 37% from fat and 15% from protein. 11 A standard protocol with ®xed sessions of physical activity, including four 10 min bouts of cycling (75 watt, in work output), was followed throughout the 24-h stay. The room temperature was maintained constant at 24 C in the daytime and 18 C at night. Spontaneous physical activity (SPA) in the respiration chamber was assessed by microwave radar (Sisor Mini-Radar, Static Input System S.A., Lausanne, Switzerland). 11 Movements disturb the radar signal, and the change in signal is recorded by the receiver. The SPA measurements indicate the percentage of time in which the subjects are active to a detectable degree. The SPA recorded during the bicycling bouts was omitted from the 24-h recording.
24-h EE was measured from 0900h ± 0900h. Sleeping EE was de®ned as the 5-h period between 0100h ± 0600h in which all the subjects were sleeping. To ensure optimal compliance to the protocol the subjects were kept under 24-h surveillance by a laboratory technician in the day-time, and by trained medical students at night. The night preceding the experiment was spent in the chamber to accustom the subjects to the environment but no measurements were carried out.
Analyses
The gas exchange of the subjects was calculated from measurements of oxygen and carbon dioxide concentrations (Ureas 3 G, Hartman and Braun analyzers, Frankfurt, Germany) at the outlet of the chamber and from measured air¯ow through the chambers. Protein oxidation was calculated from 24-h urinary nitrogen excretion. EE and oxidation of lipid and carbohydrate were calculated using standing equations as previously described. 11, 12 Immediately after the chamber stay blood was drawn from an antecubital vein without stasis in icecooled syringes and centrifuged at 4
C. Blood for determination of catecholamines was collected in tubes containing reduced glutathione and ethyleneglycol-bis(aminoethyl-ether)tetra-acetate. The tubes were centrifuged immediately and the plasma was stored at 7 80 C, until analysis by a radio enzymatic method. 13 Plasma free T. 3 was also assessed enzymtically, using kits from Serono Diagnostics SA, Switzerland.
Determination of the alanine to valine amino acid polymorphism in the UCP2 gene Genomic DNA was obtained from human leukocyte nuclei using standard methods. The polymorphism was detected by restriction fragment length polymorphism-generating polymerase chain reaction. The genomic fragment containing codon 55 of the UCP2 gene was PCR ampli®ed using primers: 5 Hgggccagtgcgcgctgcag and 5 H -catttggcgctgcaggccgg-3 H designed from the cDNA sequence. 10 The PCR product was digested with 1 u of BbvI for 1 h. Fragments were resolved on a 3% agarose gel and visualized by staining with ethidium bromide.
Statistics
The distribution of the continuous variables were described by means, standard deviations (s.d.), and with 95% con®dence intervals where appropriate.
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The phenotypic variables of the three genotypes were compared by ANCOVA with age and gender as covariates. The relationship between EE and its possible determinants was assessed by multiple linear regression analysis with stepwise forward selection (P`0.05). Data on energy expenditure were ®rst adjusted for differences in FFM using the equation
where EE act is the actual unadjusted EE, FFM mean the total group mean, FFM act is the actual FFM, and a is the slope derived from the regression analysis between FFM and EE in the total group of subjects (EE aÂFFM b). Subsequently, the same procedure was repeated to adjust for other determinants of interest. Non-protein RQ and substrate oxidations were adjusted for differences in 24-h energy balance by the same method. The siblings was considered as independent subjects in these analyses, since we previously have found that no familial effect remained on 24-h and sleeping energy expenditure after adjustment for age, gender and body size and composition. 11 The intraclass correlation coef®cient was 7 0.12 (P NS) for adjusted 24-h energy expenditure and 0.05 (P NS) for sleeping energy expenditure. A Pvalue less than 0.05 (two-tailed) was considered signi®cant. Statistical analyses were performed with Statgraphics software version 4.2 (Graphic Software Systems Inc., Rockville, MD., USA) and Sigmastat program (Jandel Scienti®c, Erkrath, Germany).
Results
The number of subjects having the three genoptypes and their frequencies were AaA (n 21, 35%), AaV (n 29, 48%) and VaV (n 10, 17%). The allelic frequency of the AaV polymorphism was 41%, which is very similar to the 48 and 46% previously reported. 10 There was no difference in age, gender, body weight or body fat mass between the three genotypes (Table 1) . Unadjusted 24-h EE and sleeping EE were not different between the genotypes (Table 2) . In a forward step-wise multiple regression analysis 90.5% of the variation in 24-h EE was explained by the covariates fat-free mass, fat mass, spontaneous physical activity and the fasting level of plasma free T 3 (P`0.0001). After 24-h EE was adjusted for these covariates the intraclass correlation coef®cient was 7 0.12 (NS), suggesting that no familial effect was left. However, an additional 0.7% was explained by UCP2 genotype (P 0.03). After adjustment for differences in fat-free mass, fat mass, and spontaneous physical activity, 24-h EE of the group with the VaV genotype was lower by 311 kJad (95% con®dence interval: 24 ± 598 kJad, P 0.03) than the AaV and AaA groups together. Adjusted 24-h EE of the VaV genotype was 299 kJad, ( 7 27 to 625 kJad) lower than the AaV heterozygotes (P 0.06), and 259 kJad (4 ± 654 kJad) lower than the AaA homozygotes (P`0.05). The 24-h spontaneous physical activity was higher in the VaV genotype by $ 20% as compared to the other genotypes separately, and the difference was most pronounced during sleep, where activity was recorded more than twice as often in the Values are means AE s.e. There are no signi®cant differences between the groups.
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VaV than in the AaA genotype (P`0.005) ( Table 2 ). The EE due to higher spontaneous physical activity fully made up for the VaV group's lower 24-h resting EE for a given body size and composition. 24-h respiratory quotient, adjusted for 24-h energy balance, age, sex and family group was slightly, but insigni®cantly, higher in the VaV genotype than in the other two groups (P 0.07) ( Table 2) . 24-h non-protein RQ, adjusted for energy balance, age, sex and spontaneous physical activity, was higher in the VaV group when compared with the AA and AaV groups (P`0.05).
Discussion
The present study reports that individuals homozygous for the variant resulting in an amino acid replacement, AaV55, of the human UCP2 gene, exhibit a phenotype with a normal 24-h EE for body size and composition, but $ 3% lower than the other genotypes after their higher spontaneous physical activity is accounted for. If this ®nding can be replicated it implies that homozygous carriers of the VaV genotype exhibit a lower 24-h resting EE for a given body size and composition. The biological functions of UCP2 are not known in detail, and based on the localization and nature of the codon 55 variant it is dif®cult to predict if the encoded protein change may cause defects in the function of UCP2. The mechanisms of H transport in UCP1 has been linked to the histidine pair H145 and H147, but the lack of both these histidines in UCP2 has raised questions about their role in H transport and as uncouplers. 14 Clearly, structure-function studies of the mutated protein are needed. However, the present study suggests that the VaV genotype may be associated with a decreased uncoupling, which phenotypically is seen as a lower 24-h resting EE for a given body size and composition. We observed no trend to phenotypic differences between the AaA and AaV genotypes, which suggests that the AaV-55 variant is a recessive trait.
Recently, Urhammer et al 10 reported no differences in the allelic frequency of the AaV-55 variant between obese and lean subjects, or any difference in body fat mass and weight gain among the AaA, AaV and VaV genotypes. However, in the Que Âbec Family Study strong evidence for linkage relationships between three different microsatellite markers encompassing the UCP2 gene location were found with resting EE in adult humans, whereas only one of the markers showed weaker evidence for linkage with body fat mass. 9 Moreover, Walder et al 15 identi®ed another polymorphism in UCP2, a 45 base pair insertiona deletion variant located 158 base pairs after the stop codon in exon 8. This polymorphism was associated with lower sleeping EE and higher BMI in Pima Indians over 45 y of age.
Whether a genetically determined low EE may cause weight gain and increase the risk of obesity may depend on the activation of regulatory mechanisms to defend body energy homeostasis. Our ®nding that individuals with the VaV genotype, apart from the lower 24-h EE, also exhibited a higher spontaneous physical activity, which tended to diminish the effect on total 24-h EE, suggests that this may be the case. The higher spontaneous physical activity may tend to counteract the lower 24-h EE and contribute to explain the observation that the VaV genotype is more weakly associated with obesity.
Spontaneous physical activity, as measured under conditions similar to those of the present study, has been shown to be a familial trait, and subjects with a low spontaneous physical activity level are at greater risk of weight gain than those with higher levels. 16 The mechanisms linking the UCP2 genotype to the higher spontaneous physical activity are unknown, but three hypotheses should be considered. One is a thermoregulatory re¯ex triggered by the lower heat production designed to maintain body core temperature, but it seems unlikely that the small difference in adjusted EE would have any thermoregulatory consequences. A second possibility is that the higher spontaneous physical activity is secondary to an enhanced metabolic ef®ciency of skeletal muscle of the VaV genotype, which makes the energetic cost of muscle contractions and movements lower, and the subsequent lower haemodynamic and respiratory burden then facilitates spontaneous physical activity in this genotype. A third possibility is that the higher SPA in the VaV genotype is primary and that the lower adjusted EE at rest in secondary. The present study does not provide data to elucidate these hypotheses further, but studies are in progress to examine the possible mechanisms. The ®nding that genotype differences in SPA were most substantial during sleep suggests that sleep state effects may be involved. In that context it is interesting that UCP2 is also expressed in the brain.
It has been suggested that UCPs may have greater importance for regulation of mitochondrial fat oxidation than for the regulation of EE. 17 Simoneau et al 18 recently reported that skeletal muscle UCP2 content was higher in obese than in lean subjects, which could be an over-expression to counteract the lower skeletal muscle fat oxidation in obesity. Therefore we also compared 24-h respiratory quotient measured at a ®xed dietary macronutrient composition. We found that fat oxidation was similar in the AaA and AaV genotypes and slightly, but insigni®cantly, lower in the VaV genotype (Table 1) . However, when we compared 24-h RQ, adjusted for energy balance, age, gender and spontaneous physical activity, the VaV genotype had signi®cantly higher values than the combined AaA and AaV groups, which could be attributed to a lower fat oxidation. This observation is in line with the recently discovered exon 6 splice junction polymorphism identi®ed in the UCP3 gene in UCP2 amino acid variant and energy expenditure A Astrup et al African Americans. In that study basal fat oxidation was reduced by 50% in donor heterozygotes compared with the wild-type individuals. 19 These observations together with our ®ndings suggest that the histidine pair is not a prerequisite for a role of UCP2 and UCP3 in metabolic fuel partitioning.
Twenty-four-hour fat oxidation, independent of habitual diet composition, has been shown to aggregate in families 20, 21 and to be under genetic in¯u-ence. 22 Moreover, individuals with a low relative fat oxidation rate are at higher risk of weight gain than those with a high relative fat oxidation. 20 The present observation therefore warrants further studies of UCP2 and UCP3 genotype effects on fat oxidation rate in larger groups of individuals.
Conclusion
Seventeen percent of the examined healthy subjects were homozygous for the codon 55 valine substitution in UCP2 and these subjects had a lower 24-h resting EE for a given body size and composition than those with the other genotypes, which suggest that this polymorphism may have functional impact by causing an increased coupling in ATP synthesis and enhanced metabolic ef®ciency. Consequently, in humans thermogenesis due to uncoupling may not be con®ned to brown adipose tissue, 23 which suggests new insights into body weight regulation and new targets for pharmacological treatment of obesity.
